Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baodong Sun

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Mikrochimica Acta|January 3, 2022
Metal oxide-based macroporous ordered double affinity molecularly imprinted polymer for specific separation and enrichment of glycoprotein from food samples: a co-modification of DMSA and boronate affinityBailin Guo, Yukui Tong, Baodong Sun, et al.
The Journal of Gene Medicine|July 22, 2009
Impaired clearance of accumulated lysosomal glycogen in advanced Pompe disease despite high-level vector-mediated transgene expressionBaodong Sun, Haoyue Zhang, Andrew Bird, et al.
Molecular Genetics and Metabolism Reports|August 2, 2017
A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe diseaseHan-Hyuk Lim, Haiqing Yi, Takashi K Kishimoto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoterBaodong Sun, Haoyue Zhang, Luis M Franco, et al.
The Journal of Gene Medicine|October 23, 2010
Antibody formation and mannose-6-phosphate receptor expression impact the efficacy of muscle-specific transgene expression in murine Pompe diseaseBaodong Sun, Songtao Li, Andrew Bird, et al.
Cytokine|March 1, 2021
Elevated interleukin-37 associated with tophus and pro-inflammatory mediators in Chinese gout patientsLiping Ding, Heng Li, Baodong Sun, et al.
American Journal of Human Genetics|October 10, 2007
Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune toleranceBaodong Sun, Andrew Bird, Sarah P Young, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 11, 2014
Correction of glycogen storage disease type III with rapamycin in a canine modelHaiqing Yi, Elizabeth D Brooks, Beth L Thurberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2003
Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vectorBaodong Sun, Y-T Chen, Andrew Bird, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 2017
Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe diseaseHaiqing Yi, Tao Sun, Dustin Armstrong, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Mikrochimica Acta|January 3, 2022
Metal oxide-based macroporous ordered double affinity molecularly imprinted polymer for specific separation and enrichment of glycoprotein from food samples: a co-modification of DMSA and boronate affinityBailin Guo, Yukui Tong, Baodong Sun, et al.
The Journal of Gene Medicine|July 22, 2009
Impaired clearance of accumulated lysosomal glycogen in advanced Pompe disease despite high-level vector-mediated transgene expressionBaodong Sun, Haoyue Zhang, Andrew Bird, et al.
Molecular Genetics and Metabolism Reports|August 2, 2017
A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe diseaseHan-Hyuk Lim, Haiqing Yi, Takashi K Kishimoto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoterBaodong Sun, Haoyue Zhang, Luis M Franco, et al.
The Journal of Gene Medicine|October 23, 2010
Antibody formation and mannose-6-phosphate receptor expression impact the efficacy of muscle-specific transgene expression in murine Pompe diseaseBaodong Sun, Songtao Li, Andrew Bird, et al.
Cytokine|March 1, 2021
Elevated interleukin-37 associated with tophus and pro-inflammatory mediators in Chinese gout patientsLiping Ding, Heng Li, Baodong Sun, et al.
American Journal of Human Genetics|October 10, 2007
Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune toleranceBaodong Sun, Andrew Bird, Sarah P Young, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 11, 2014
Correction of glycogen storage disease type III with rapamycin in a canine modelHaiqing Yi, Elizabeth D Brooks, Beth L Thurberg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2003
Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vectorBaodong Sun, Y-T Chen, Andrew Bird, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 2017
Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe diseaseHaiqing Yi, Tao Sun, Dustin Armstrong, et al.
Pageof 6